Increased risk for invasive breast cancer associated with hormonal therapy: a nation-wide random sample of 65,723 women followed from 1997 to 2008.

BACKGROUND: Hormonal therapy (HT) either estrogen alone (E-alone) or estrogen plus progesterone (E+P) appears to increase the risk for breast cancer in Western countries. However, limited information is available on the association between HT and breast cancer in Asian women characterized mainly by...

Full description

Bibliographic Details
Main Authors: Jung-Nien Lai, Chien-Tung Wu, Pau-Chung Chen, Chiun-Sheng Huang, Song-Nan Chow, Jung-Der Wang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3188542?pdf=render
_version_ 1819094253250281472
author Jung-Nien Lai
Chien-Tung Wu
Pau-Chung Chen
Chiun-Sheng Huang
Song-Nan Chow
Jung-Der Wang
author_facet Jung-Nien Lai
Chien-Tung Wu
Pau-Chung Chen
Chiun-Sheng Huang
Song-Nan Chow
Jung-Der Wang
author_sort Jung-Nien Lai
collection DOAJ
description BACKGROUND: Hormonal therapy (HT) either estrogen alone (E-alone) or estrogen plus progesterone (E+P) appears to increase the risk for breast cancer in Western countries. However, limited information is available on the association between HT and breast cancer in Asian women characterized mainly by dietary phytoestrogens intake and low prevalence of contraceptive pills prescription. METHODOLOGY: A total of 65,723 women (20-79 years of age) without cancer or the use of Chinese herbal products were recruited from a nation-wide one-million representative sample of the National Health Insurance of Taiwan and followed from 1997 to 2008. Seven hundred and eighty incidents of invasive breast cancer were diagnosed. Using a reference group that comprised 40,052 women who had never received a hormone prescription, Cox proportional hazard models were constructed to determine the hazard ratios for receiving different types of HT and the occurrence of breast cancer. CONCLUSIONS: 5,156 (20%) women ever used E+P, 2,798 (10.8%) ever used E-alone, and 17,717 (69%) ever used other preparation types. The Cox model revealed adjusted hazard ratios (HRs) of 2.05 (95% CI 1.37-3.07) for current users of E-alone and 8.65 (95% CI 5.45-13.70) for current users of E+P. Using women who had ceased to take hormonal medication for 6 years or more as the reference group, the adjusted HRs were significantly elevated and greater than current users and women who had discontinued hormonal medication for less than 6 years. Current users of either E-alone or E+P have an increased risk for invasive breast cancer in Taiwan, and precautions should be taken when such agents are prescribed.
first_indexed 2024-12-21T23:24:28Z
format Article
id doaj.art-1b48dff7bc7a4a6fbaadbd0369331c4d
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T23:24:28Z
publishDate 2011-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-1b48dff7bc7a4a6fbaadbd0369331c4d2022-12-21T18:46:41ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-01610e2518310.1371/journal.pone.0025183Increased risk for invasive breast cancer associated with hormonal therapy: a nation-wide random sample of 65,723 women followed from 1997 to 2008.Jung-Nien LaiChien-Tung WuPau-Chung ChenChiun-Sheng HuangSong-Nan ChowJung-Der WangBACKGROUND: Hormonal therapy (HT) either estrogen alone (E-alone) or estrogen plus progesterone (E+P) appears to increase the risk for breast cancer in Western countries. However, limited information is available on the association between HT and breast cancer in Asian women characterized mainly by dietary phytoestrogens intake and low prevalence of contraceptive pills prescription. METHODOLOGY: A total of 65,723 women (20-79 years of age) without cancer or the use of Chinese herbal products were recruited from a nation-wide one-million representative sample of the National Health Insurance of Taiwan and followed from 1997 to 2008. Seven hundred and eighty incidents of invasive breast cancer were diagnosed. Using a reference group that comprised 40,052 women who had never received a hormone prescription, Cox proportional hazard models were constructed to determine the hazard ratios for receiving different types of HT and the occurrence of breast cancer. CONCLUSIONS: 5,156 (20%) women ever used E+P, 2,798 (10.8%) ever used E-alone, and 17,717 (69%) ever used other preparation types. The Cox model revealed adjusted hazard ratios (HRs) of 2.05 (95% CI 1.37-3.07) for current users of E-alone and 8.65 (95% CI 5.45-13.70) for current users of E+P. Using women who had ceased to take hormonal medication for 6 years or more as the reference group, the adjusted HRs were significantly elevated and greater than current users and women who had discontinued hormonal medication for less than 6 years. Current users of either E-alone or E+P have an increased risk for invasive breast cancer in Taiwan, and precautions should be taken when such agents are prescribed.http://europepmc.org/articles/PMC3188542?pdf=render
spellingShingle Jung-Nien Lai
Chien-Tung Wu
Pau-Chung Chen
Chiun-Sheng Huang
Song-Nan Chow
Jung-Der Wang
Increased risk for invasive breast cancer associated with hormonal therapy: a nation-wide random sample of 65,723 women followed from 1997 to 2008.
PLoS ONE
title Increased risk for invasive breast cancer associated with hormonal therapy: a nation-wide random sample of 65,723 women followed from 1997 to 2008.
title_full Increased risk for invasive breast cancer associated with hormonal therapy: a nation-wide random sample of 65,723 women followed from 1997 to 2008.
title_fullStr Increased risk for invasive breast cancer associated with hormonal therapy: a nation-wide random sample of 65,723 women followed from 1997 to 2008.
title_full_unstemmed Increased risk for invasive breast cancer associated with hormonal therapy: a nation-wide random sample of 65,723 women followed from 1997 to 2008.
title_short Increased risk for invasive breast cancer associated with hormonal therapy: a nation-wide random sample of 65,723 women followed from 1997 to 2008.
title_sort increased risk for invasive breast cancer associated with hormonal therapy a nation wide random sample of 65 723 women followed from 1997 to 2008
url http://europepmc.org/articles/PMC3188542?pdf=render
work_keys_str_mv AT jungnienlai increasedriskforinvasivebreastcancerassociatedwithhormonaltherapyanationwiderandomsampleof65723womenfollowedfrom1997to2008
AT chientungwu increasedriskforinvasivebreastcancerassociatedwithhormonaltherapyanationwiderandomsampleof65723womenfollowedfrom1997to2008
AT pauchungchen increasedriskforinvasivebreastcancerassociatedwithhormonaltherapyanationwiderandomsampleof65723womenfollowedfrom1997to2008
AT chiunshenghuang increasedriskforinvasivebreastcancerassociatedwithhormonaltherapyanationwiderandomsampleof65723womenfollowedfrom1997to2008
AT songnanchow increasedriskforinvasivebreastcancerassociatedwithhormonaltherapyanationwiderandomsampleof65723womenfollowedfrom1997to2008
AT jungderwang increasedriskforinvasivebreastcancerassociatedwithhormonaltherapyanationwiderandomsampleof65723womenfollowedfrom1997to2008